| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 医药制造儿童类药(元) | 356,805,481.68 | 936,348,576.73 | 502,058,078.36 | 1,535,950,304.55 | 787,487,732.88 |
| 医药制造慢性病类药(元) | 132,568,306.49 | 369,920,397.64 | 316,847,912.45 | 770,184,610.93 | 366,901,415.63 |
| 医药其他及服务(元) | - | 46,687,950.02 | - | 19,331,720.13 | - |
| 其他(元) | 94,424,310.99 | 97,273,370.89 | 93,618,929.17 | 177,980,368.86 | - |
| 营业成本(元) | |||||
| 医药制造儿童类药(元) | 77,703,253.92 | 249,261,632.37 | 87,967,491.13 | 221,670,438.10 | 111,559,116.14 |
| 医药制造慢性病类药(元) | 108,048,579.86 | 227,134,992.74 | 103,833,726.22 | 147,176,319.79 | 59,471,857.66 |
| 医药其他及服务(元) | - | - | - | - | - |
| 其他(元) | 57,799,885.80 | - | 61,240,347.01 | - | - |
| 毛利(元) | |||||
| 医药制造儿童类药(元) | 279,102,227.76 | 687,086,944.36 | 414,090,587.23 | 1,314,279,866.45 | 675,928,616.74 |
| 医药制造慢性病类药(元) | 24,519,726.63 | 142,785,404.90 | 213,014,186.23 | 623,008,291.14 | 307,429,557.97 |
| 医药其他及服务(元) | - | - | - | - | - |
| 其他(元) | 36,624,425.19 | - | 32,378,582.16 | - | - |
| 毛利率(%) | |||||
| 医药制造儿童类药(%) | 78.22 | 73.38 | 82.48 | 85.57 | 85.83 |
| 医药制造慢性病类药(%) | 18.50 | 38.60 | 67.23 | 80.89 | 83.79 |
| 医药其他及服务(%) | - | - | - | - | - |
| 其他(%) | 38.79 | - | 34.59 | - | - |
| 收入构成(%) | |||||
| 医药制造儿童类药(%) | 61.12 | 64.57 | 55.02 | 61.35 | 68.22 |
| 医药制造慢性病类药(%) | 22.71 | 25.51 | 34.72 | 30.76 | 31.78 |
| 医药其他及服务(%) | - | 3.22 | - | 0.77 | - |
| 其他(%) | 16.17 | 6.71 | 10.26 | 7.11 | - |
| 毛利构成(%) | |||||
| 医药制造儿童类药(%) | 82.03 | 82.79 | 62.79 | 67.84 | 68.74 |
| 医药制造慢性病类药(%) | 7.21 | 17.21 | 32.30 | 32.16 | 31.26 |
| 医药其他及服务(%) | - | 0.00 | - | 0.00 | - |
| 其他(%) | 10.76 | 0.00 | 4.91 | 0.00 | - |
